Large-scale mobilization and isolation of CD34+ cells from normal donors

被引:15
作者
Croop, JM
Cooper, R
Seshadri, R
Fernandez, C
Graves, V
Kreissman, S
Smith, FO
Cornetta, K
Williams, DA
Abonour, R
机构
[1] Indiana Univ, James Whitcomb Riley Hosp Children, Sect Pediat Hematol Oncol, Sch Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, James Whitcomb Riley Hosp Children, Herman B Wells Ctr Pediat Res, Sch Med, Indianapolis, IN 46202 USA
[3] Indiana Univ, Riley Apheresis Ctr, Sch Med,Dept Med, Div Biostat, Indianapolis, IN 46202 USA
[4] Indiana Univ, Sch Med, Stem Cell Lab, Dept Pathol, Indianapolis, IN 46202 USA
[5] Indiana Univ, Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA
[6] Indiana Univ, Sch Med, Howard Hughes Med Inst, Indianapolis, IN 46202 USA
关键词
PBSC; PBPC; mobilization; apheresis; CD34; Isolex;
D O I
10.1038/sj.bmt.1702720
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We describe collection and purification of peripheral blood CD34(+) cells from volunteer, normal donors and allogeneic stem cell donors. A total of 98 aphereses were performed on 68 volunteer donors using peripheral venous access, The mean number of nucleated cells collected was 4.6 x 10(10) which included 1,9 x 10(8) CD34(+) cells corresponding to 2.7 x 10(6) CD34(+) cells/kg, The number of CD34(+) cells collected did not differ between males and females but did correlate with the donor's weight and the total number of nucleated cells collected. The Nexell Isolex 300i cell separator was used to isolate CD34+ cells from 30 of the collections. A mean of 0.36% of the total cells was recovered and included 43 +/- 18% of the CD34(+) cells. CD34(+) cells represented 85 +/- 11% of the recovered cells. The total number of CD34(+) cells recovered was not influenced by the number of nucleated cells placed on the Isolex 300i, The percentage of CD34(+) cells recovered was not related to the number of CD34(+) cells placed on the Isolex 300i. The purity of the final product was influenced by the number of CD34(+) cells but not the total number of nucleated cells. An additional 38 CD34(+) cell isolations were performed on normal allogeneic stem cell donors with similar results. These observations further support the safety and feasibility of peripheral blood CD34(+) cell collection and purification.
引用
收藏
页码:1271 / 1279
页数:9
相关论文
共 63 条
[41]   CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment [J].
Noga, SJ ;
Seber, A ;
Davis, JM ;
Berenson, RJ ;
Vogelsang, GB ;
Braine, HG ;
Hess, AD ;
Marcellus, D ;
Miller, CA ;
Sharkis, SJ ;
Goodman, SN ;
Santos, GW ;
Jones, RJ .
JOURNAL OF HEMATOTHERAPY, 1998, 7 (02) :151-157
[42]   Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34(+) peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies [J].
Ogura, M ;
Kagami, Y ;
Suzuki, R ;
Miura, K ;
Uehira, K ;
Kurokawa, T ;
Ito, T ;
Kinoshita, T ;
Emi, N ;
Morishima, Y ;
Kodera, Y ;
Ueda, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) :S51-S57
[43]   Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow [J].
Ottinger, HD ;
Beelen, DW ;
Scheulen, B ;
Schaefer, UW ;
GrosseWilde, H .
BLOOD, 1996, 88 (07) :2775-2779
[44]  
Papadimitriou C A, 1995, J Hematother, V4, P539, DOI 10.1089/scd.1.1995.4.539
[45]   Purging peripheral blood progenitor cell grafts from lymphoma cells: Quantitative comparison of immunomagnetic CD34(+) selection systems [J].
Paulus, U ;
Dreger, P ;
Viehmann, K ;
vonNeuhoff, N ;
Schmitz, N .
STEM CELLS, 1997, 15 (04) :297-304
[46]   Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL [J].
Paulus, U ;
Schmitz, N ;
Viehmann, K ;
vonNeuhoff, N ;
Dreger, P .
BONE MARROW TRANSPLANTATION, 1997, 20 (05) :415-420
[47]   Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies [J].
Pavletic, ZS ;
Bishop, MR ;
Tarantolo, SR ;
MartinAlgarra, S ;
Bierman, PJ ;
Vose, JM ;
Reed, EC ;
Gross, TG ;
Kollath, J ;
Nasrati, K ;
Jackson, JD ;
Armitage, JO ;
Kessinger, A .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1608-1616
[48]   The efficiency of tumor cell purging using immunomagnetic CD34(+) cell separation systems [J].
RootsWeiss, A ;
Papadimitriou, C ;
Serve, H ;
Hoppe, B ;
Koenigsmann, M ;
Reufi, B ;
Oberberg, D ;
Thiel, E ;
Berdel, WE .
BONE MARROW TRANSPLANTATION, 1997, 19 (12) :1239-1246
[49]   Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system [J].
Rowley, SD ;
Loken, M ;
Radich, J ;
Kunkle, LA ;
Mills, BJ ;
Gooley, T ;
Holmberg, L ;
McSweeney, P ;
Beach, K ;
MacLeod, B ;
Appelbaum, F ;
Bensinger, WI .
BONE MARROW TRANSPLANTATION, 1998, 21 (12) :1253-1262
[50]  
RUSSELL NH, 1994, BONE MARROW TRANSPL, V13, P353